HealthTree Logo
search more_vert
person Sign In / Create Account
RESCHEDULED: A Nationwide Trial for Smoldering Myeloma Patients
RESCHEDULED: A Nationwide Trial for Smoldering Myeloma Patients image
MGUS/Smoldering Myeloma
event Mar 04, 2024 / 01:00PM - 02:00PM EST

Event Description

Drs. Cowan and Callander join the MGUS/Smoldering Myeloma community to share with us the nationwide ECOG/SWOG clinical trial, ECOG DETER SMM in which a Dara Rd regimen is being compared to Rd treatment across the nation for smoldering myeloma treatment.

As many of you, we remain hopeful with the amount of accelerated research being done in the smoldering and precursor myeloma fields.

We're excited to learn from them. Come with questions and learn how to enroll in this groundbreaking trial!

Schedule & Agenda

The panelist Audrey Burton-Bethke
1:00 PM
Audrey Burton-Bethke

Audrey introduces the agenda of the event and our featured speakers Dr. Andrew J. Cowan and Dr. Natalie Callander.

1:05 PM
Dr. Andrew J. Cowan and Dr. Natalie Callander

Dr. Andrew J. Cowan and Dr. Natalie Callander share with us the nationwide ECOG/SWOG clinical trial.

Questions and Answers
1:35 PM

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Natalie Callander, MD
Natalie Callander, MD

Natalie Callander, MD joined the section of Hematology/Bone Marrow Transplant at the University of Wisconsin in October 2004 as an Associate Professor in the Department of Medicine. Dr. Callander graduated from Tufts University School of Medicine in Boston, MA, has completed residency at Bellevue Hospital in New York, as well as a Hematology/Oncology fellowship at the University of California-San Diego. Her board certifications include hematology, internal medicine, and medical oncology.

Read Bio
The panelist Andrew J Cowan, MD
Andrew J Cowan, MD

Dr. Andrew Cowan is a hematologist-oncologist who specializes in treating patients with multiple myeloma and other blood disorders. He leads clinical trials of new treatments for these diseases, including the use of engineered immune cells, combination strategies and genomics data. An expert in trial design, Dr. Cowan evaluates research proposals as a member of Fred Hutchinson Cancer Research Center's Scientific Review Committee.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us




Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube